Michal Vaľko | Global Health | Research Excellence Award

Published on by Health Scientists

Mr. Michal Vaľko | Global Health | Research Excellence Award

Researcher | Katolícka univerzita v Ružomberku | Slovakia

Michal Vaľko is a multidisciplinary researcher whose work bridges public health, digital society, and behavioral sciences, with a growing focus on how lifestyle, technology, and social environments shape human wellbeing. His academic training at the Catholic University in Ružomberok established a strong foundation in social sciences and analytical research, which he has expanded through studies examining cardiovascular risk patterns across European populations, workplace wellbeing among young employees, and the psychological effects of social media on adolescents. His contributions include publications in global health, environmental sustainability, educational psychology, and social responsibility, demonstrating an ability to work across domains where health, behavior, and digital ecosystems intersect. He has collaborated with international scholars in public health, artificial intelligence, and behavioral science, contributing to research on carbon-labeling policies, explainable AI for lifestyle medicine, and personality-based educational analytics. His work is frequently grounded in both qualitative and quantitative methods, supported by proficiency in statistical tools and a sustained engagement with digital-behavior research. Beyond academic publishing, he has actively participated in conferences addressing digital safety, youth wellbeing, and interdisciplinary social challenges, earning recognition for excellence in scholarly work, including awards for research on adolescent cognitive functioning in the digital age and academic achievement within his faculty. His ongoing community-oriented engagements, including volunteer roles in digital communication and participation in participatory research initiatives with older adults, highlight a commitment to public-facing scholarship and societal impact. With a research profile that integrates health sciences, social informatics, and ethical considerations around technology, he contributes to emerging discussions on how digital transformations influence health outcomes, behavioral patterns, and institutional responsibility. This combination of interdisciplinary scholarship, international collaboration, and applied societal engagement positions him as an emerging voice in contemporary health-behavior research and digital-societal studies. He has 3 citations from 4 documents with an h-index of 1.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Valko, M., Walker, M. D., Htoon, A., Dumlao, J., Lane, H., Lee, I. G., Amer, H., & Bursova, J. (2025). If Europe lived the same lifestyle: Insights into cardiovascular risk from the European Social Survey. Global Health Journal.

2. Lane, H., Pokutnia, O., Walker, M. D., Killingsworth, J., Valko, M., & Farias, A. R. (2025). What is carbon labeling of food and does it work? A preliminary review of the potential impact of carbon labeling on consumer choice. Green and Low-Carbon Economy.

3. Valko, M., Walker, M. D., & Lane, H. (2025). The impact of working hours and tenure on the wellbeing of young employees in Slovakia. Journal of Workplace Behavioral Health.

4. Gioia, F., Vaľko, M., & Lane, H. (2025). Exploration of the Big Five: Educational correlations, dimensionality reduction and clustering techniques (Preprint).

5. Vaľko, M. (2023). Vplyv sociálnych sietí na fungovanie mysle adolescentov. ŠVOČ in Social Work – Bachelor Section.

Mai Kadry | Global Health | Editorial Board Member

Published on by Health Scientists

Assist. Prof. Dr. Mai Kadry | Global Health | Editorial Board Member 

Research Scientist | National Research Center | Egypt

Mai O. Kadry is a distinguished researcher at the National Research Centre in Giza, Egypt, recognized for her multidisciplinary contributions across metabolomics, molecular oncology, nanomedicine, toxicology, and women’s health research. Her scientific portfolio reflects a sustained commitment to unraveling the biochemical and molecular mechanisms underpinning complex diseases, with a particular focus on metabolic disorders, cancer progression, reproductive toxicology, and innovative therapeutic strategies. Through a substantial body of peer-reviewed publications, she has advanced understanding of how metabolic signatures, genomic interactions, and molecular signaling pathways can be leveraged to improve disease diagnosis, treatment response, and therapeutic safety. Her work frequently integrates serum metabolomics, network pharmacology, lipidomics, nanostructure-based drug delivery, and experimental validation models, enabling a comprehensive systems-level view of disease processes. She has collaborated extensively with national and international scientists, contributing to multidisciplinary studies on phytotherapeutics for endocrine disorders, nanoscale interventions to mitigate chemotherapeutic toxicity, and molecular crosstalk driving drug resistance in cancer cells. Her authorship and citation footprint reflect broad scholarly engagement, while her active participation in multi-institutional teams has supported knowledge exchange and capacity building within the biomedical research community. Kadry’s investigations into natural product therapeutics, oxidative brain injury mechanisms, autophagy regulation, and emerging RNA-based biomarkers contribute to public health and precision medicine, offering insights with potential translational relevance to women’s health, oncology, toxicology, and environmental exposure science. Collectively, her work demonstrates a strong commitment to scientific innovation, interdisciplinary integration, and the societal importance of developing safer, more effective therapeutic approaches that align with global health priorities. She has 462 citations from 50 documents with an h-index of 12.

Profiles: Scopus | ORCID

Featured Publications

1. Kadry, M., Author, A. A., Author, B. B., … (2025). Exploring the therapeutic potential of marjoram (Origanum majorana L.) in polycystic ovary syndrome: Insights from serum metabolomics, network pharmacology and experimental validation.

2. Kadry, M., & Author, A. A. (2025). Novel insights into SNORD-78 and miR-122-5P: The predicted diagnostic indexes of lung cancer—Drug-loaded liposome formulations competing methylcholanthrene-induced lung cancer.

3. Kadry, M., Author, A. A., Author, B. B., Author, C. C., & Author, D. D. (2025). Oxidative brain injury ascending from DMBA: Metabolomics and BRAF3/FKBR/A2m molecular signaling crosstalk.

4. Kadry, M., Author, A. A., Author, B. B., … (2025). Metabolomics integrated genomics approach: Understanding multidrug resistance phenotype in MCF-7 breast cancer cells exposed to doxorubicin and ABCA1/EGFR/PI3K/PTEN crosstalk.

5. Kadry, M., Author, A. A., & Author, B. B. (2025). Titanium nanostructure mitigating doxorubicin-induced testicular toxicity in rats via regulating major autophagy signaling pathways.

Duo Liu | Epidemiology | Best Researcher Award

Published on by Health Scientists

Prof. Duo Liu | Epidemiology | Best Researcher Award 

Deputy Director, Department of Clinical Pharmacy | Harbin Medical University | China

Professor Duo Liu, Chief Pharmacist and Doctoral Supervisor at Harbin Medical University Cancer Hospital, is a distinguished pharmaceutical scientist whose research has significantly advanced the fields of pharmacogenomics, pharmacoepidemiology, and precision oncology. With a strong background in medical genetics and pharmacology, Professor Liu has developed a research portfolio that bridges molecular pharmacology with clinical translation, focusing on the genetic mechanisms underlying cancer susceptibility, therapeutic response, and drug resistance. His pioneering contributions include transcriptome-wide association studies identifying novel genetic determinants of pancreatic and prostate cancer risk, as well as investigations into the role of NADPH oxidase polymorphisms and oxidative stress in tumor biology and treatment outcomes. Professor Liu’s scholarly work, published in leading international journals such as Cancer Research, Carcinogenesis, and International Journal of Cancer, has garnered wide recognition for its methodological rigor and clinical relevance. He has successfully led multiple national and institutional research grants, including projects supported by the National Natural Science Foundation of China, and has been honored with several prestigious distinctions for excellence in pharmaceutical sciences and young investigator achievements. As an active member of numerous professional societies, including the Chinese Pharmacological Society and the Anti-Cancer Association of China, Professor Liu contributes to shaping the evolving landscape of cancer pharmacotherapy and drug epidemiology. His collaborations with global research institutions, notably the University of Hawaii Cancer Center, underscore his commitment to advancing international scientific exchange and translational medicine. Through his leadership in clinical pharmacy and mentorship of emerging scientists, Professor Liu continues to drive innovation in personalized cancer treatment and rational drug use, promoting evidence-based healthcare practices that enhance patient outcomes and public health impact worldwide.

Profile: ORCID 

Featured Publications

1. Chen, C., Dong, Q., Wang, H., Dong, S., Wang, S., Lin, W., Jia, C., Dong, M., Jin, Y., & Liu, D. (2025, January 8). The association between NADPH oxidase (NOX) polymorphisms with immunohistochemistry and survival in diffuse large B cell lymphoma patients. Annals of Hematology.

2. Wang, S. F., Dong, S. Q., Dong, Q., Lin, W. X., Dong, M., & Liu, D. (2024). Natural product-induced oxidative stress-synergistic anti-tumor effects of chemotherapeutic agents. Traditional Medicine Research.

3. Dong, S., Chen, C., Di, C., Wang, S., Dong, Q., Lin, W., & Liu, D. (2024, December). The association between NADPH oxidase 2 (NOX2) and drug resistance in cancer. Current Cancer Drug Targets.

4. Liu, D., Bae, Y. E., Zhu, J., Zhang, Z., Sun, Y., Deng, Y., Wu, C., & Wu, L. (2023, December 15). Splicing transcriptome-wide association study to identify splicing events for pancreatic cancer risk. Carcinogenesis.

5. Liu, D., Zhao, T., Zhu, J., Sharapov, S., Tiys, E., & Wu, L. (2023, December 4). Associations between genetically predicted plasma N-glycans and pancreatic cancer risk. All Life.